Flywheel, AIQ to offer cancer therapy response system

By The Science Advisory Board staff writers

October 7, 2020 -- Flywheel and AIQ Solutions have partnered to offer a data management and analysis system aimed at boosting scientists' understanding of treatment responses for complex diseases, including cancer.

Using Flywheel's cloud-scale data management and collaboration platform and AIQ's technology, the scalable system can improve patient management and the overall delivery of accurate data for specific diseases, according to the firms.

The system aims to help physicians and researchers develop optimal treatment plans for their patients and ultimately improve patient outcomes.

Hexagon Bio secures $47M to advance drug discovery platform
Hexagon Bio has closed $47 million in series A financing to advance its drug discovery capabilities on its fungal genomics-based platform.
Integral Molecular adds to its antibody discovery platform
Integral Molecular has developed humanized chicken antibody technology and incorporated it into its MPS antibody discovery platform for multipass membrane...
Omega Therapeutics advances epigenomic programming platform
Omega Therapeutics has received $85 million in financing to support clinical trials of its epigenomic controllers for programs in oncology, inflammation,...
Flywheel unveils life sciences imaging platform
Research informatics firm Flywheel has introduced an enterprise-wide image management platform geared for the life sciences market.

Copyright © 2020

Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter